Email Alert RSS
Volume 13 Issue 5
Sep.  2022
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2022  >  13(5): 783-788
Chinese Medicine Group, Clinical Epidemiology and Evidence-based Medicine Association of Chinese Medical Association. Expert Consensus on Clinical Research Methodology of Traditional Chinese Medicine in the New Era[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 783-788. doi: 10.12290/xhyxzz.2022-0428
Citation: Chinese Medicine Group, Clinical Epidemiology and Evidence-based Medicine Association of Chinese Medical Association. Expert Consensus on Clinical Research Methodology of Traditional Chinese Medicine in the New Era[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 783-788. doi: 10.12290/xhyxzz.2022-0428
shu

Expert Consensus on Clinical Research Methodology of Traditional Chinese Medicine in the New Era

doi: 10.12290/xhyxzz.2022-0428
More Information

    Corresponding author: HU Jingqing, E-mail: gcp306@126.com

  • Received Date: 2022-08-05
  • Accepted Date: 2022-08-17
    • Available Online: 2022-09-15
  • Publish Date: 2022-09-30
    Abstract
  • To address the challenges of the new era and promote the rational application of clinical epidemiology and evidence-based medicine methods in traditional Chinese medicine (TCM), Chinese Medicine Group, the Clinical Epidemiology and Evidence-based Medicine Association of Chinese Medical Association, gathered the related experts from all over the country and developed a consensus to improve the application of clinical epidemiology and evidence-based medicine methods in TCM. Delphi survey, consensus meetings and nominal groups were adopted in the process. This consensus summarizes the major challenges in the research of TCM and provides theoretical guidance for the development and application of clinical epidemiology and evidence-based medicine in TCM.
    • FullText(HTML)
  • loading
    • References(32)
  • [1] 符宇, 邵明义, 赵瑞霞, 等. 基于中医证据的中医临床疗效评价方法探讨[J]. 中医杂志, 2020, 61: 1124-1129. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202013005.htm
    [2] 陈可冀, 钱振淮, 张问渠, 等. 精制冠心片双盲法治疗冠心病心绞痛112例疗效分析[J]. 中华心血管病杂志, 1982, 10: 85-89. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ198211015.htm
    [3] 李幼平, 刘鸣. 循证医学与中医药现代化[J]. 中国中医药信息杂志, 1999, 6: 14-16, 32. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY199912008.htm
    [4] Zhang YQ, Jiao RM, Witt CM. How to design high quality acupuncture trials-a consensus informed by evidence[J]. BMJ, 2022, 376: e067476.
    [5] 衣琳. 探究"天人合一"思想对中医学影响[J]. 中西医结合心血管病电子杂志, 2019, 7: 21, 23. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXJH201914013.htm
    [6] Thomas SK. The Structure of Scientific Revolutions[M]. Chicago: University of Chicago Press, 1996: 1-212.
    [7] 张新江, 张新雪, 赵宗江. 中西医结合研究范式的思考与探索[J]. 世界科学技术-中医药现代化, 2021, 23: 3859-3865. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202111004.htm
    [8] Rapport F, Braithwaite J. Are we on the cusp of a fourth research paradigm?Predicting the future for a new approach to methods-use in medical and health services research[J]. BMC Med Res Methodol, 2018, 18: 131. doi:  10.1186/s12874-018-0597-4
    [9] Guyatt GH, Oxman AD, Schvnemann HJ. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology[J]. J Clin Epidemiol, 2011, 64: 380-382. doi:  10.1016/j.jclinepi.2010.09.011
    [10] 吴大嵘. 浅谈中医多来源证据特点及其评析方法[C]. 第八届中医/中西医结合循证医学方法研讨会会议材料, 2014: 42-43.
    [11] 陈薇, 方赛男, 刘建平. 基于证据体的中医药临床证据分级标准建议[J]. 中国中西医结合杂志, 2019, 39: 358-364. doi:  10.7661/j.cjim.20190123.062
    [12] 牟玮, 翟静波, 李杰, 等. 中医临床证据的转化策略—决策辅助工具的研制[J]. 世界中医药, 2017, 12: 1261-1267. doi:  10.3969/j.issn.1673-7202.2017.06.012
    [13] 刘保延, 王永炎. 证候、证、症的概念及其关系的研究[J]. 中医杂志, 2007, 48: 293-296, 298. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ200704000.htm
    [14] 宋美芳, 陈家旭, 彭晨习, 等. 论中医微观辨证[J]. 中华中医药杂志, 2019, 34: 2867-2869. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201907007.htm
    [15] 春柳, 谢洋, 赵虎雷, 等. 基于文献的中医证候诊断规范研制现状分析[J]. 中医杂志, 2021, 62: 169-172. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202102017.htm
    [16] 陶嘉磊, 袁斌, 汪受传. 中医证候学研究的技术方法及其运用现状[J]. 中华中医药杂志, 2018, 33: 2982-2985. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201807076.htm
    [17] 于东林, 胡镜清. 关于中医证候诊断标准研究的思考[J]. 中华中医药杂志, 2021, 36: 4110-4113. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107085.htm
    [18] 吴朦. 中医复杂干预临床研究报告规范研究[D]. 北京: 中国中医科学院, 2014.
    [19] 吴朦. 中风病气虚血瘀证中医复杂干预研究与综合评价[D]. 北京: 中国中医科学院, 2017.
    [20] 董斐, 刘建平. 从"经验"到"证据": 循证医学促进中医药传承创新发展[J]. 南京中医药大学学报, 2021, 37: 642-647. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202105002.htm
    [21] Sedgwick P. Understanding the ecological fallacy[J]. BMJ, 2015, 351: h4773.
    [22] Huang K, Zhang P, Zhang Z. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms[J]. Pharmacol Ther, 2021, 225: 107843.
    [23] 梁宁, 陈雅馨, 李慧珍, 等. 新型冠状病毒肺炎疫情下快速动态化制订循证中医指南的思考[J]. 中国中西医结合杂志, 2022, 42: 218-222. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202202014.htm
    [24] Ziemssen T, Medin J, Couto CAM. Multiple sclerosis in the real world: A systematic review of fingolimod as a case study[J]. Autoimmun Rev, 2017, 16: 355-376.
    [25] Izquierdo G, Damas F, Pápamo MD. The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study[J]. PloS One, 2017, 12: e0176174.
    [26] Ziemssen T, Lang M, Tackenberg B. Real-world persistence and benefit-risk. profile of fingolimod over 36 months in Germany[J]. Neurol Neuroimmunol Neuroinflamm, 2019, 6: e548.
    [27] 贾玉龙, 姚明宏, 刘艳梅, 等. 特许医疗政策下真实世界数据治理的模式探索[J]. 中国循证医学杂志, 2021, 21: 1373-1380. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202112001.htm
    [28] 柏柳安宁, 夏结来, 王陵, 等. 真实世界研究中的常见偏倚及其控制[J]. 中国临床药理学与治疗学, 2020, 25: 1422-1428. https://www.cnki.com.cn/Article/CJFDTOTAL-YLZL202012016.htm
    [29] 刘保延. 真实世界的中医临床科研范式[J]. 中医杂志, 2013, 54: 451-455. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201306003.htm
    [30] 张润顺, 王映辉, 刘保延, 等. 基于共享系统的真实世界中医临床研究范式初步实施方案的设计[J]. 中医杂志, 2014, 55: 1551-1554. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201418008.htm
    [31] 李昱佳, 陈垂雄, 黄丽红, 等. 不同领域现实世界临床研究证据转化的应用策略[J]. 中国临床医学, 2021, 28: 744-750. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202105005.htm
    [32] Li M, Chen S, Lai Y. Integrating Real-World Evidence in. the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model[J]. Front Med (Lausanne), 2021, 8: 669509.
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (4262) PDF downloads(180) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return